Bio-Rad Laboratories Inc Class A

BIO: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$825.00GdhmqWgscgsk

Bio-Rad: Initiating Coverage With Wide Moat Rating and $430 Fair Value Estimate; Shares Undervalued

We initiate coverage of Bio-Rad with a wide moat rating and $430 fair value estimate. We think the company is an attractive long-term investment with significant margin expansion opportunities in its consolidated businesses. Although the company’s profit margins have historically lagged peers, we think the market does not sufficiently appreciate Bio-Rad's progress and momentum in improving its cost structure.

Sponsor Center